Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in the United Kingdom with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Unknown status Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20111
20161
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clatterbridge Centre for Oncology1
Lymphoma Study Association1
NovalGen Ltd.1
Scotland and Newcastle Lymphoma Group1
St. Bartholomew's Hospital1
Telios Pharma, Inc.1
University College, London1
University of Glasgow1
University of Surrey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell9
Lymphoma, Follicular7
Lymphoma6
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin5
Hodgkin Disease4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Waldenstrom Macroglobulinemia4

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.